Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hit or miss: the use of melatonin supplements.

Literature DB >> 33054970

Hit or miss: the use of melatonin supplements.

Cathy A Goldstein¹, Helen J Burgess².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2020 PMID： 33054970 PMCID： PMC7792888 DOI： 10.5664/jcsm.8896

Source DB: PubMed Journal: J Clin Sleep Med ISSN： 1550-9389 Impact factor: 4.062

× No keyword cloud information.

11 in total

1. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin.

Authors: J B Fourtillan; A M Brisson; P Gobin; I Ingrand; J P Decourt; J Girault
Journal: Biopharm Drug Dispos Date: 2000-01 Impact factor: 1.627

2. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content.

Authors: Lauren A E Erland; Praveen K Saxena
Journal: J Clin Sleep Med Date: 2017-02-15 Impact factor: 4.062

3. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.

Authors: James K Wyatt; Derk-Jan Dijk; Angela Ritz-de Cecco; Joseph M Ronda; Charles A Czeisler
Journal: Sleep Date: 2006-05 Impact factor: 5.849

Review 4. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors: Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal: CNS Drugs Date: 2019-12 Impact factor: 5.749

5. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light.

Authors: A J Lewy; V K Bauer; S Ahmed; K H Thomas; N L Cutler; C M Singer; M T Moffit; R L Sack
Journal: Chronobiol Int Date: 1998-01 Impact factor: 2.877

6. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.

Authors: Nina Buscemi; Ben Vandermeer; Nicola Hooton; Rena Pandya; Lisa Tjosvold; Lisa Hartling; Glen Baker; Terry P Klassen; Sunita Vohra
Journal: J Gen Intern Med Date: 2005-12 Impact factor: 5.128

7. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg.

Authors: Helen J Burgess; Victoria L Revell; Thomas A Molina; Charmane I Eastman
Journal: J Clin Endocrinol Metab Date: 2010-04-21 Impact factor: 5.958

8. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors: R Robert Auger; Helen J Burgess; Jonathan S Emens; Ludmila V Deriy; Sherene M Thomas; Katherine M Sharkey
Journal: J Clin Sleep Med Date: 2015-10-15 Impact factor: 4.062

Hit or miss: the use of melatonin supplements.

1. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin.

2. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content.

3. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.

Review 4. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

5. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light.

6. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.

7. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg.

9. Meta-analysis: melatonin for the treatment of primary sleep disorders.

10. Individual differences in the amount and timing of salivary melatonin secretion.

Review 1. Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights.

Review 2. Machine and Deep Learning in Molecular and Genetic Aspects of Sleep Research.

Review 3. Melatonin/Cyclodextrin Inclusion Complexes: A Review.